Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
54.9M
-
Shares change
-
+7.8M
-
Total reported value, excl. options
-
$199M
-
Value change
-
+$28.6M
-
Put/Call ratio
-
0.78
-
Number of buys
-
51
-
Number of sells
-
-19
-
Price
-
$3.62
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2024
89 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2024.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.9M shares
of 98M outstanding shares and own 55.99% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (14.7M shares), FMR LLC (12.1M shares), Point72 Asset Management, L.P. (4.88M shares), VANGUARD GROUP INC (3.6M shares), Tikvah Management LLC (2.46M shares), Woodline Partners LP (1.68M shares), BlackRock, Inc. (1.53M shares), Alyeska Investment Group, L.P. (1.28M shares), Logos Global Management LP (1M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.